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Introduction {#sec1}
============

T helper 17 (Th17) cells are intensely studied because of their known role in the pathogenicity of a variety of inflammatory disorders ([@bib56], [@bib58]). However, less well understood are the characteristics of tissue-resident homeostatic intestinal Th17 cells that differentiate in response to the microbiota, notably segmented filamentous bacteria (SFB), and fulfil important roles in protection of the gut barrier ([@bib8], [@bib29]). To complicate matters further, intestinal Th17 cell responses are also linked with the pathology of inflammatory bowel disease (IBD) ([@bib21]), and it has been suggested that intestinal Th17 cells contribute to inflammatory disease elsewhere in the body ([@bib30], [@bib61]).

Substantial efforts have been made to define gene regulatory networks that discriminate pathogenic and non-pathogenic Th17 cells ([@bib14], [@bib31]). A caveat is that this distinction is so far largely on the basis of Th17 cells generated *in vitro* in the presence of different cytokine cocktails compared with Th17 cells isolated from the inflamed central nervous system (CNS) of mice with active experimental autoimmune encephalomyelitis (EAE). Because Th17 cells are influenced by the local tissue environment they find themselves in and are affected by a multitude of environmental factors, including diet ([@bib11], [@bib24], [@bib62]), aryl hydrocarbon receptor (AHR) ligands ([@bib65]), circadian rhythm ([@bib64]), and the microbiota, it is unlikely that *in*-*vitro*-differentiated Th17 cells recapitulate the spectrum of biology present in *ex vivo* Th17 cells. Here, we have therefore focused on intestinal Th17 cells either present during homeostasis or induced by infection. This was done by comparing the characteristics of SFB-induced Th17 cells and those of Th17 cells differentiating in response to a pathogen (*Citrobacter rodentium*). Th17 cells induced in response to *C. rodentium* are necessary for clearing the infection, and this results in transient but reversible tissue damage due to their inflammatory properties.

At present, it is unclear what distinguishes inflammatory Th17 cells elicited by pathogens (e.g., *C. rodentium*) and homeostatic tissue-resident Th17 cells elicited by commensals (e.g., SFB). A further consideration is the success in therapeutic targeting of inflammatory Th17 cells in conditions such a psoriasis, or multiple sclerosis via antibodies against interleukin-17A (IL-17A) or IL-12p40 ([@bib40]). Such antibodies, on the other hand, proved to worsen the symptoms of Crohn's patients ([@bib19]). Although reduction of inflammatory cytokine production by Th17 cells does not directly affect the cells themselves, other strategies such as inhibition of retinoic acid-related orphan receptors γt (RORγt) might compromise the maintenance of the homeostatic intestinal Th17 cell population. Transient inhibition of RORγt in a mouse model has been shown to reduce Th17 cell differentiation in response to infection with *C. rodentium*, while sparing group 3 innate lymphoid cells (ILC3s), however the effect on resident small intestinal Th17 cells was not tested ([@bib59]). It is therefore important to understand the intrinsic differences between inflammatory and tissue-resident Th17 cells to ascertain that future therapies directed against inflammatory Th17 cells do not inadvertently damage the resident gut population.

Our data show that tissue-resident homeostatic Th17 cells induced by SFB do not participate in inflammatory reactions and exhibit a transcriptional profile indicating downmodulation of inflammatory capacity. In contrast, Th17 cells elicited in response to *C. rodentium* exhibit a high degree of plasticity towards an inflammatory cytokine profile and a transcriptome reflecting inflammatory effector potential. Furthermore, the metabolism of tissue-resident homeostatic Th17 cells resembles more that of resting memory cells, whereas *C.*-rodentium-elicited Th17 cells primarily engage aerobic glycolysis that is commonly associated with inflammatory effector cells. Our findings indicate that there are two functionally distinct Th17 cell populations that might reside in the gut simultaneously.

Results {#sec2}
=======

Segmented Filamentous Bacteria and *Citrobacter rodentium* Induce Qualitatively Different Th17 Responses {#sec2.1}
--------------------------------------------------------------------------------------------------------

SFB are one of the most potent and well-characterized commensal inducers of Th17 cells. Indeed, monocolonization of germ-free mice with SFB promotes a robust Th17 cell response in the small intestinal lamina propria and to a minor extent in the large intestine lamina propria ([@bib20]). To further explore Th17 cell induction by SFB, we colonized SFB-negative specific-pathogen free (SPF) mice with SFB by oral gavage with feces from SFB monocolonized germ-free mice. Subsequently, SFB-containing feces were collected from the SFB^+^ mice housed in our SPF colony and used to introduce SFB into experimental mice. To trace the kinetics of Th17 differentiation upon SFB colonization, we introduced SFB into IL-17A fate reporter mice (*Il17a*^Cre^*R26R*^eYFP^) by oral gavage, and Th17 cells, permanently marked as eYFP^+^ cells, as well as SFB colonization were then monitored 1, 2, and 4 weeks later. SFB abundance peaked in the feces of colonized mice one week after introduction and then diminished over time ([Figure 1](#fig1){ref-type="fig"}A). Although SFB abundance was lower at week 4, it remained detectable at any later time-point, in accordance with other reports showing that SFB is contained after introduction into wild-type animals, but never completely cleared ([@bib27]). The expansion and containment of SFB correlated with the induction and contraction of Th17 cell numbers in the small intestinal lamina propria ([Figure 1](#fig1){ref-type="fig"}B), confirming that Th17 cells are induced upon SFB expansion and, in turn, contribute to control SFB load. Although SFB is confined to the small intestine (SI), Th17 cells were also found in the colon after colonization with SFB, albeit at lower numbers ([Figure S1](#mmc1){ref-type="supplementary-material"}A).Figure 1Colonization with SFB and Infection with *C. rodentium* Induce Different Th17 Responses(A) Relative abundance of SFB in the feces of mice reconstituted with SFB^+^ feces on 0 (n = 10), 1 (n = 10), 2 (n = 12), and 4 (n = 6) weeks after gavage. SFB genomic 16s was quantified in the feces by qPCR analysis. Abundance of SFB was normalized to Eubacteria.(B and D) Absolute numbers of Th17 cells in the small intestine of mice colonized with SFB (B) and colon of mice infected with *C. rodentium* (D) at 0 (n = 6 and 5), 1 (n = 10 and 6), 2 (n = 11 and 6), and 4 (n = 10 and 9) weeks after gavage.(C) *C. rodentium* burden in the colon of infected mice at 0 (n = 5), 1 (n = 6), 2 (n = 6), and 4 (n = 9) weeks after gavage.In the graphs, bars show the mean ± SEM (A, B, and D) or median (C) and each symbol represents an individual mouse from two pooled independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001 by one-way ANOVA with Dunnett's post-test. n.d., not detected. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Although SFB colonization results in generation of Th17 cells in the small intestine, infections with intestinal pathogens such as *Citrobacter rodentium* that target the colon also induce Th17 responses ([@bib34]). To understand whether homeostatic SFB-elicited Th17 cells and pro-inflammatory *C.*-*rodentium*-elicited Th17 cells are induced with similar kinetics, we infected SFB-free *Il17a*^Cre^*R26R*^eYFP^ mice with *C. rodentium* and followed Th17 cell induction in the colon on weeks 1, 2, and 4. Similarly to what was observed for SFB, the bacterial load of *C. rodentium* reached its peak in the first week and then progressively declined until it was cleared by week 4 ([Figure 1](#fig1){ref-type="fig"}C). Th17 cells induced by *C. rodentium* peaked at week 2, similarly to those induced by SFB, however *C.*-rodentium-elicited Th17 cells had not contracted by week 4 despite complete bacterial clearance ([Figure 1](#fig1){ref-type="fig"}D).

Th17 cells elicited by *C. rodentium* are known to produce large amounts of interferon-γ (IFN-γ) ([@bib1]). In contrast, Th17 cells generated upon SFB colonization produce mostly IL-17A ([@bib20]), although a different study reported a modest increase in IFN-γ upon SFB colonization ([@bib12]). Due to differences in animal models, chosen time points and intestinal microbiota composition in these studies, it is difficult to draw conclusions regarding the cytokine profiles of Th17 cells elicited in these two conditions. For this reason, we compared cytokine production after *ex vivo* stimulation with phorbol myristate acetate (PMA) and ionomycin of eYFP^+^ Th17 cells from *Il17a*^Cre^*R26R*^eYFP^ mice, colonized with either SFB or *C. rodentium*. Th17 cells generated in the first week mostly expressed IL-22 with IL-17A, or just IL-17A in either condition ([Figures 2](#fig2){ref-type="fig"}A and 2B) and started expressing IFN-γ, especially in *C.*-*rodentium*-infected mice, in the later phase of the infection (at 2 and 4 weeks), consistent with published reports on SFB- and *C.*-*rodentium*-elicited T cells ([@bib2]). Although a transient induction of IFN-γ^+^IL-17A^+^ Th17 cells was observed in SFB colonized mice at 2 weeks after infection, the proportion of IFN-γ^+^IL-17A^−^ Th17 cells was significantly higher in *C. rodentium* colonized mice than in SFB colonized mice at all time points. ([Figures 2](#fig2){ref-type="fig"}C and 2D). SFB-elicited Th17 cells resident in the colon displayed a similar profile throughout the chosen time points compared with time points of homeostatic small intestinal Th17 cells ([Figure S2](#mmc1){ref-type="supplementary-material"}A). In contrast *C.*-*rodentium*-elicited Th17 cells found in the small intestine diverged from their counterpart in the colon after the first week and showed a muted cytokine expression ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Although re-stimulation with PMA and ionomycin is a useful tool to identify subpopulations of Th17 cells based on their cytokine production, it does not necessarily reflect the actual production of the protein *in vivo*. For this reason, we FACS-sorted intestinal Th17 cells from *Il17a*^Cre^*R26R*^eYFP^ mice colonized with SFB or *C. rodentium* 2 weeks after infection and cultured them without further stimulation to assess their production of cytokines on the protein level. Interestingly, IL-22 was secreted to a similar extent by SFB- and *C.*-*rodentium*-elicited Th17 cells, whereas IL17-A secretion was higher in SFB-induced Th17 cells, and increased amounts of IFN-γ were secreted only by *C.*-*rodentium*-elicited Th17 cells ([Figure 2](#fig2){ref-type="fig"}E).Figure 2SFB- and *C.*-*rodentium*-Elicited Th17 Cells Have Different Cytokine Profiles(A--D) Representative intracellular staining for IL-17A and IL-22 (A) or IFN-γ (C) and corresponding quantifications in (B) and (D) in Th17 cells from the SI of mice colonized with SFB and colon of mice infected with *C. rodentium* at 1 (n = 9 and 6), 2 (n = 11 and 6), and 4 (n = 14 and 9) weeks after gavage. Lamina propria cells were isolated at the indicated time point, re-stimulated with PMA and ionomycin and Brefeldin A for 2 h, and analyzed by FACS. Bars show the mean ± SEM for the indicated populations, and each symbol represents an individual mouse from two pooled independent experiments.(E) Cytokine concentration in supernatants of FACS-purified Th17 cells from the SI of mice colonized with SFB or colon of mice infected with *C. rodentium*. In the graphs, bars show the mean ± SEM, and each symbol represents a technical replicate. Cells were FACS-purified from one sample per group, obtained by pooling 3--6 mice. Results are representative of three independent experiments.(F) Fold-change (FC) induction of listed genes quantified by qPCR in the SI (green) and colon (orange) of mice colonized with SFB or infected with *C. rodentium*, 1 week after gavage. Fold change is calculated on the matching organs from untreated mice and gene expression is normalized against β-2-microglobulin. Data are from two pooled independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.0001 by two-way ANOVA with Sidak's post-test. Please see also [Figure S2](#mmc1){ref-type="supplementary-material"}.

In order to investigate what factors might mediate the differences in functionality between SFB- and *C.*-*rodentium*-elicited Th17 cells, we next determined whether SFB versus *C. rodentium* infection induces different molecules in intestinal tissue samples comprising epithelial and hematopoietic cells ([Figures 2](#fig2){ref-type="fig"}F and [S2](#mmc1){ref-type="supplementary-material"}C).

As previously reported, SFB infection led to upregulation of serum amyloid A1 (*Saa1*) in the small intestinal tissue, which is linked with the induction of Th17 cells ([@bib45]). This was also observed, to a lesser extent, in the colon of SFB-colonized mice, but not in tissue samples from *C.*-*rodentium*-infected mice. Also characteristic for SFB was the induction of fructosyltransferase 2 (*Fut2*) which was shown to foster bacterial species that metabolize fucosylated substrates and protect against infection with *Salmonella typhimurium* ([@bib48]). Dual oxidase maturation factor 2 (*Duoxa2*), the maturation factor for reactive oxygen species (ROS)-generating enzyme dual oxidase 2 (Duox2) was upregulated both in tissue from SFB- as well as *C.*-*rodentium*-infected mice. This is consistent with the role of ROS in the induction of SFB- as well as *C.*-*rodentium*-elicited intestinal Th17 cells ([@bib2]). *Il23a*, *Il1b*, *Cxcl1*, and *Cxcl2* on the other hand were barely induced in intestinal tissue samples by SFB colonization, whereas they were highly expressed in colonic but not small intestinal tissue from *C.*-*rodentium*-infected mice.

Thus, infection with a commensal bacterium compared with a pathogen has distinct consequences for the response of epithelial and hematopoietic cells in mucosal tissue.

Cytokine Responses of Th17 Cells in the Periphery Recapitulate Their Intestinal Counterparts {#sec2.2}
--------------------------------------------------------------------------------------------

We next investigated the dissemination of Th17 cells elicited by SFB or *C. rodentium* into the periphery over a time point of 4 weeks after colonization. SFB-elicited Th17 cells were detectable in the spleen, albeit at very low numbers. In contrast, *C.*-*rodentium*-elicited Th17 cells seeded the periphery in substantial numbers with a peak 2 weeks after infection, but still showed high numbers 4 weeks later ([Figure 3](#fig3){ref-type="fig"}A). FACS-sorted Th17 cells from the spleen and intestine were then cultured with dendritic cells (DCs) and immunodominant epitopes for either SFB or *C. rodentium* (EspA) to determine cytokine production in response to recall. SFB-induced Th17 cells isolated from the small intestine produced some IL-22 and IL-17A, but not IFN-γ even without re-stimulation, whereas those isolated from the spleen did not produce cytokines unless re-stimulated, but then recapitulated the specificity and cytokine profile of small intestinal Th17 cells ([Figure 3](#fig3){ref-type="fig"}B). *C.*-*rodentium*-induced Th17 cells isolated from the colon as well as the spleen produced concentrations of IL-22 and IL-17A protein upon re-stimulation, but in contrast to SFB-specific Th17 cells, they produced particularly high amounts of IFN-γ ([Figure 3](#fig3){ref-type="fig"}C). Thus, SFB-specific Th17 cells have very limited expansion potential and are found in very small numbers only in the periphery where re-stimulation by SFB peptide illustrates their origin and specificity as well as their imprinted cytokine profile. *C.*-*rodentium*-induced Th17 cells on the other hand distribute to the periphery in large numbers and exhibit an inflammatory cytokine profile indicative of plasticity towards a Th1-like cytokine pattern with high protein concentrations of IFN-γ.Figure 3Peripheral Th17 Cells Retain Their Antigen-Specificity in Response to SFB and *C. rodentium*Shown in (A) are the absolute numbers of Th17 cells in the spleen of mice colonized with SFB or infected with *C. rodentium* at 0 (n = 11 and 5), 1 (n = 10 and 6), 2 (n = 12 and 6), and 4 (n = 6 and 8) weeks after gavage. Symbols show the mean ± SEM. Cytokine concentration in supernatants of FACS-purified Th17 cells from the spleen and SI of mice colonized with SFB (B) or from the spleen and colon of mice infected with *C. rodentium* (C), cultured with DCs and SFB peptide (B) or EspA (C). Bars show the mean + SEM of technical replicates (n = 3--4). Cells were FACS-purified from one sample per group, obtained by pooling 3--6 mice. Results are representative of three (B) and two (C) independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001 by two-way (A) or one-way (B and C) ANOVA with Sidak's (A) or Tukey's (B and C) post-test. n.d., not detected. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Homeostatic Tissue-Resident Th17 Cells Do Not Clear *C. rodentium* Infection {#sec2.3}
----------------------------------------------------------------------------

Small intestinal Th17 cells that arise in response to commensal microbes such as SFB might be expected to display a "non-inflammatory" cytokine profile. However, SFB and intestinal Th17 cells have been implicated in inflammatory disorders outside the intestine, including EAE ([@bib30], [@bib61]). To understand whether the presence of intestinal Th17 cells influences the course of EAE in our model of SFB re-introduction, we immunized SFB^+^ and SFB^−^ mice with oligodendrocyte glycoprotein peptide in complete Freund\'s adjuvant (MOG-CFA) to induce EAE. Although clear differences in SFB abundance ([Figure S3](#mmc1){ref-type="supplementary-material"}A) and numbers of intestinal Th17 cells ([Figure S3](#mmc1){ref-type="supplementary-material"}B) were observed between the two groups, there was no difference in disease onset and severity after immunization with MOG-CFA ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Furthermore, frequency of Th17 cells in the spinal cord ([Figure S3](#mmc1){ref-type="supplementary-material"}D) did not vary between SFB^+^ and SFB^−^ mice. This suggests that induction of inflammatory Th17 cell responses in the periphery are not influenced by resident intestinal Th17 cells and the presence of SFB.

However, Th17 cells are clearly involved in inflammatory processes within the intestinal environment, such as IBD, but it remains to be determined whether pro-inflammatory Th17 cells contributing to intestinal inflammation are Th17 cells *de novo* generated under pro-inflammatory conditions or rather tissue-resident "homeostatic" Th17 cells elicited by SFB that acquire a pro-inflammatory phenotype. To address this question, we colonized mice with SFB to induce differentiation of tissue-resident homeostatic Th17 cells in the intestine and then infected them with *C. rodentium*. Intestinal Th17 cell differentiation is initiated in the mesenteric lymph node (mLN) and the cells subsequently migrate to the intestinal lamina propria ([@bib49]). To block the migration of newly generated *C.*-rodentium-specific Th17 cells from the mLN to the intestine, we administered the drug FTY720 after SFB colonization ([@bib38]), as illustrated in [Figure 4](#fig4){ref-type="fig"}A. FTY720 is an analogue of sphingosine-1-phosphate, and its administration prevents lymphocyte egress from the lymph nodes and trafficking to target tissues ([@bib7]).Figure 4Homeostatic Tissue-Resident Intestinal Th17 Cells Do Not Clear *C. rodentium* Infection(A) Schematic drawing of the experimental protocol. Mice were orally gavaged with SFB^+^ feces 4 weeks before the infection with *C. rodentium* (at day 0). Six days before the infection with *C. rodentium* (day −6), mice were intra-peritoneally injected with FTY720 (3 mg/kg) or control vehicle every day. FTY720 and control vehicle administration continued after the infection every other day until the end of the experiment.(B) Survival curve of *C.*-*rodentium*-infected mice treated with vehicle or FTY720.(C) *C. rodentium* burdens in colon and liver.(D--J) Absolute numbers of colonic Th17 cells. Representative intracellular staining for IL-17A and IFN-γ (E) or IL-22 (H) and quantification (F and I) in colonic Th17 cells. IFN-γ (G) and IL-22 (J) protein content in colon explant cultures. Bars show median (C) or mean ± SEM (D, F, G, I, and J) and each symbol represents an individual mouse (n = 8). Results are representative of three independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 by Mantel-Cox (B), Mann-Whitney (C) or Student's t test (D, F, G, I, and J). See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

FTY720 treatment did not affect the numbers or cytokine profile of SFB-elicited Th17 cells in the colon, and they remained at a baseline number of 3.7 × 10^3^ cells ([Figure S4](#mmc1){ref-type="supplementary-material"}A--S4C).

Upon infection with *C. rodentium,* SFB-colonized mice treated with FTY720 succumbed to the infection between day 9 and 14 ([Figure 4](#fig4){ref-type="fig"}B) and displayed higher bacterial loads in the colon and dissemination to the liver compared than mice receiving only the vehicle ([Figure 4](#fig4){ref-type="fig"}C). Vehicle-treated mice infected with *C. rodentium* showed an increase in the Th17 population to 8.7 × 10^4^ cells. Administration of FTY720 resulted in a marked decrease in numbers of colonic Th17 cells ([Figure 4](#fig4){ref-type="fig"}D), back to baseline numbers seen after Th17 cell induction by SFB ([Figure S1](#mmc1){ref-type="supplementary-material"}A). This suggested that SFB-elicited Th17 cells resident in the colon did not expand in response to *C. rodentium*. Moreover, a smaller number of colonic Th17 cells from FTY720-treated mice were IFN-γ^+^IL-17A^+^ and IFN-γ^+^IL-17A^−^ compared with Th17 cells from mice treated with the vehicle ([Figures 4](#fig4){ref-type="fig"}E and 4F).

Consistently, production of IFN-γ was markedly decreased in the colons of mice receiving the drug ([Figure 4](#fig4){ref-type="fig"}G). Thus, Th17 cells elicited by SFB and resident in the colon of FTY720-treated mice did not acquire the "classical" Th17 pro-inflammatory phenotype observed in Th17 cells elicited by *C. rodentium* infection, whereas the latter could not contribute IFN-γ because their migration to the colon was blocked by FTY720. Furthermore, the proportion of IL-22-producing cells and protein concentration of IL-22 were substantially reduced ([Figure 4](#fig4){ref-type="fig"}H--4J) in line with the finding that the major source of IL-22 beyond day 5 after infection are adaptive T cells with a Th17 cell origin ([@bib1], [@bib3]). However, the number of ILC3s, which supply IL-22 prior to the induction of the adaptive response, was not affected by FTY720 treatment in *C.*-*rodentium*-infected mice ([Figure S4](#mmc1){ref-type="supplementary-material"}D).

As *C.*-*rodentium*-specific Th17 cells were blocked from entry into the intestine, the infection could not be contained, and the mice succumbed to bacterial dissemination.

Homeostatic Tissue-Resident and Inflammatory Intestinal Th17 Cells Are Characterized by Distinct Metabolism {#sec2.4}
-----------------------------------------------------------------------------------------------------------

To characterize the molecular state associated with the different functional activities of Th17 cells induced by commensal SFB versus the pathogen *C. rodentium*, we profiled the transcriptome of these two populations by using RNA-sequencing (RNA-seq). We colonized mice with either SFB or *C. rodentium* and harvested Th17 cells from both small intestine and colon after 2 weeks at the peak of Th17 cell expansion. Hierarchical clustering revealed that the greatest variations in gene expression occurred between Th17 cells isolated from the colon of *C.*-*rodentium*-infected mice and the remaining three groups, including Th17 cells from the small intestine and colon of SFB-colonized mice and from the small intestine of *C.*-*rodentium*-infected mice ([Figure 5](#fig5){ref-type="fig"}A). *C*.-*rodentium*-elicited Th17 cells from the SI displayed higher similarity to homeostatic Th17 from the SI and colon of mice colonized with SFB than to inflammatory Th17 cells from the colon of mice colonized with *C*. *rodentium*. ([Figure 5](#fig5){ref-type="fig"}A). In correspondence with what was previously observed at the protein level ([Figure 2](#fig2){ref-type="fig"}E), small intestinal SFB-elicited Th17 cells expressed higher read counts for *Il17a* and comparable read counts for *Il22* compared with pro-inflammatory *C.*-*rodentium*-derived colonic Th17 cells. Furthermore, reads for T-box-containing protein expressed in T cells (*Tbx21)* and *Ifng*, which are expressed by Th17 cells that switch towards a pro-inflammatory profile, were increased in *C.*-*rodentium*- but not SFB-induced colonic Th17 cells ([Figure 5](#fig5){ref-type="fig"}B).Figure 5Intestinal Th17 Cells Elicited by SFB and *C. rodentium* Have Distinct Transcriptional Profiles(A) RNA-sequencing analysis of Th17 cells from the SI and colon of *C. rodentium* (Citro)-infected and SFB-colonized mice, presented as heatmap of condition similarity showing Poisson distance between experimental groups.(B) Gene expression in Th17 cells from the SI and colon of *C.*-*rodentium*-infected and SFB-colonized mice, presented as normalized read counts (TPM).(C) Scatter plot of differentially expressed genes (log~2~-fold change) in SFB SI versus *C. rodentium* colon against SFB colon versus *C. rodentium* colon. Each dot represents a gene differentially expressed (adjusted p \< 0.05) in at least one comparison. Specifically, genes in green are significantly different in the SFB SI versus *C. rodentium* colon comparison; genes in blue are significantly different in SFB colon versus *C. rodentium* colon comparison; and genes in red are significantly different in both comparisons.(D) Top 15 canonical pathways in colonic SFB- versus *C. rodentium*-induced Th17 cells identified by ingenuity pathway analysis (IPA) and ranked on p value. The colors indicate activation *Z*-score of each pathway with red corresponding to positive *Z*-scores, blue to negative *Z*-scores, and white to no activity pathway available. ^∗^p \< 0.05, ^∗∗^p \< 0.01 by one-way ANOVA with Tukey's post-test. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

The natural habitat for SFB is the small intestine, whereas *C. rodentium* colonizes the colon. Considering the high degree of similarity between SFB-elicited Th17 cells from the colon and the small intestine, we asked whether the comparison between these two homeostatic populations and inflammatory *C.*-*rodentium*-derived colonic Th17 cells would result in similar sets of differentially expressed genes. As shown in [Figure 5](#fig5){ref-type="fig"}C, the vast majority of differentially expressed genes appeared in both comparisons: SFB-derived colonic Th17 cells versus *C.*-*rodentium*-derived colonic Th17 cells and SFB-derived small intestinal Th17 cells versus *C.*-*rodentium*-derived colonic Th17 cells. Moreover, this similarity trend persisted also in the non-differentially expressed genes with only a handful of genes exhibiting opposite trends in the two comparisons. For this reason, we decided to use SFB-elicited colonic Th17 cells as our homeostatic control population and compared it to inflammatory *C.*-*rodentium*-elicited colonic Th17 cells.

A consistent observation for SFB-elicited Th17 cells was the inhibition of pro-inflammatory pathways, including Janus kinase (JAK) and signal transducers and activators of transcription (STAT) signaling, nitric oxide, and ROS production compared with that in *C.*-*rodentium*-derived Th17 cells ([Figure 5](#fig5){ref-type="fig"}D). In contrast, anti-inflammatory pathways, such as sumoylation, phosphatase and tensin homolog (PTEN), and sirtuin signaling were activated in SFB-derived Th17 cells. Expression of *Sirt1*, which belongs to the sirtuin family of NAD^+^-dependent deacetylases, is downregulated in IBD biopsies and increased in mucosal samples of IBD patients successfully treated with Infliximab ([@bib6]).

Transcriptional regulators and chromatin modifiers involved in regulating cell growth, differentiation, and apoptosis such as *Rhob, Znf217*, *Rnd3*, *Xiap*, *EP300*, and *Sp1* were upregulated in SFB-induced Th17 cells ([Figure S5](#mmc1){ref-type="supplementary-material"}A) as were signaling modifiers, cell cycle inhibitors, and anti-apoptotic factors connected to the PTEN pathway ([Figure S5](#mmc1){ref-type="supplementary-material"}B). A further indication of the less inflammatory nature of SFB-elicited Th17 cells is the enrichment for mitochondria-encoded genes involved in oxidative phosphorylation (OXPHOS) (*mt-Nd1*, *mt-Nd2*, *mt-Nd3*, *mt-Nd4*, *mt-Nd4l*, and *mt-Nd6*) compared with markers of gluconeogenesis and glycolysis such as *Crtc2* and *Ldha*, respectively, that are downregulated in SFB-elicited Th17 cells but highly expressed on inflammatory *C.*-*rodentium*-elicited Th17 cells ([Figure S5](#mmc1){ref-type="supplementary-material"}C).

In order to investigate whether our RNA-seq data from *ex vivo* intestinal Th17 cells show any overlap with *in vitro* generated "pathogenic" versus "non-pathogenic" Th17 cells, we compared our dataset from colonic SFB- versus *C.*-*rodentium*-elicited Th17 cells to published gene expression data from Th17 cells differentiated in the presence of transforming growth factor-β (non-pathogenic Th17) or IL-23 (pathogenic Th17) ([@bib15]). Out of 197 genes differentially expressed between pathogenic and non-pathogenic *in*-*vitro*-differentiated Th17 cells, 189 genes were detectable in colonic SFB- or *C.*-*rodentium*-elicited Th17 cells. Among these 189 genes (depicted in [Figure S5](#mmc1){ref-type="supplementary-material"}D), 33 genes were differentially expressed to a significant extent in our dataset and followed a consistent trend in tissue-resident, SFB-elicited Th17 cells compared with *in vitro* "regulatory" Th17 cells as well as in *C.*-*rodentium*-elicited Th17 cells compared with "pathogenic" Th17 cells ([Figures S5](#mmc1){ref-type="supplementary-material"}D--S5F). Markers previously observed in "non-pathogenic" versus "pathogenic" *in*-*vitro*-differentiated Th17 cells, such as *Maf*, *Il10*, or *Tbx21* were differentially expressed in SFB versus *C. rodentium* Th17 cells, respectively ([Figure S5](#mmc1){ref-type="supplementary-material"}D--S5F).

Further focus on the metabolism in the two Th17 cell types illustrated that *C.*-*rodentium*-elicited Th17 cells were enriched in metabolic pathways such as pyruvate metabolism, amino acid biosynthesis, purine, and pyrimidine metabolisms ([Figure 6](#fig6){ref-type="fig"}A). The usage of these metabolic pathways is consistent with the behavior of activated T cells, which display increased capacity for glucose uptake, pyruvate generation, and demand for nucleotides and other biomass to support their rapid proliferation and generation of effector molecules ([@bib39]). Effector T cells also increase mitochondrial OXPHOS upon activation, together with anaerobic glycolysis, although the latter remain the most substantially increased metabolism in these cells ([@bib54], [@bib56]). In accordance with this observation, expression profile analysis indicated an upregulation of both OXPHOS and glycolytic pathways in *C.*-*rodentium*-induced Th17 cells, whereas tissue-resident homeostatic Th17 cells seemed to rely mainly on OXPHOS ([Figure 6](#fig6){ref-type="fig"}A). To further investigate metabolic phenotypes of tissue-resident homeostatic and *C.*-*rodentium*-elicited Th17 cells, we used reporter metabolite analysis and identified those metabolites around which transcriptional changes occur (see [STAR Methods](#sec4){ref-type="sec"}). This analysis showed that tissue-resident homeostatic Th17 cells upregulated reducing agents, including nicotinamide adenine dinucleotide phosphate (NADPH) and glutathione (GSH) ([Figure 6](#fig6){ref-type="fig"}B and [Table S1](#mmc1){ref-type="supplementary-material"}), which are crucial to balance the oxidative stress generated by OXPHOS. *C.*-*rodentium*-elicited Th17 cells, on the other hand, upregulated energy metabolites in the cytosol ([Figure 6](#fig6){ref-type="fig"}B and [Table S1](#mmc1){ref-type="supplementary-material"}) and genes encoding glycolytic enzymes (*Hk1*, *Pfkl*, *Aldoa*, *Eno1*, *Pkm*, and *Ldha*) ([Figure 6](#fig6){ref-type="fig"}C).Figure 6SFB- and *C.*-*rodentium*-elicited intestinal Th17 cells display different metabolic phenotypes(A) Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathways enriched in SFB- and *C.-rodentium*-elicited colonic Th17 cells, on the basis of upregulated genes with adjusted p \< 0.001.(B) Selection of differentially upregulated reporter metabolites involved in energy generation and redox reactions in SFB- and *C.-rodentium*-elicited colonic Th17 cells (adjusted p \< 0.05).(C) Metabolism-related genes increased in *C.*-*rodentium*-induced colonic Th17 cells (adjusted p \< 0.05) (in red) as well as the associated reactions involved in glycolysis. See also [Table S1](#mmc2){ref-type="supplementary-material"}.

Given that the RNA-seq data suggested pronounced metabolic differences between the tissue-resident and infection-induced Th17 cells, we carried out extracellular flux analysis in order to define the bioenergetic profiles of these populations. The basal oxygen consumption rate (OCR), an indicator of OXPHOS, was slightly higher in *C.*-*rodentium*- than in SFB-derived intestinal Th17 cells ([Figure 7](#fig7){ref-type="fig"}A). Furthermore, we observed a significant increase of extracellular acidification rate (ECAR), an indicator of glycolysis, in *C.*-*rodentium*-elicited Th17 cells ([Figure 7](#fig7){ref-type="fig"}B). These cells also displayed higher ATP-coupled respiration than did SFB-derived Th17 cells ([Figure 7](#fig7){ref-type="fig"}C), in agreement with the reporter metabolite analysis in [Figure 6](#fig6){ref-type="fig"}B. Collectively, these data support the findings from our RNA-seq analysis and suggest that *C.*-*rodentium*-derived Th17 cells exhibit an energetic glycolytic phenotype, whereas SFB-derived Th17 cells show a resting aerobic profile, mainly dependent on OXPHOS ([Figure 7](#fig7){ref-type="fig"}D).Figure 7SFB- and *C.*-*rodentium*-Intestinal Th17 Cells Have Distinct Bioenergetic Profiles and Mitochondrial MorphologyTh17 cells from the SI of SFB-colonized mice and the colon of *C.*-*rodentium*-infected mice were FACS-sorted and used for further analysis.(A) Oxygen consumption rate (OCR) at baseline and in response to oligomycin (Oligo), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP), and rotenone plus antimycin (R + A).(B) Baseline extracellular acidification rate (ECAR) in relation to ECAR of SFB-elicited Th17 cells.(C) Measurement of ATP-coupled respiration.(D) OCR (measure of OXPHOS) plotted against ECAR (measure of glycolysis). Data are from 2--3 pooled independent experiments and are shown as mean ± SEM ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001 by Student's t test.(E--H) *Z*-stack images were used to evaluate mitochondrial morphology by confocal microscopy. Mitochondria were stained with MitoTracker Red CMXRos (red), nuclei with DAPI (blue), and actin with Alexa Fluor 488 phalloidin (green). A magnification (top) and a 3D surface rendered image (bottom) of the area indicated in white are shown (E). Quantification of individual mitochondria (F), mean mitochondrial branch length (G), and mitochondrial area per cell (H) obtained using MiNa Macro and Fiji software. In the violin plot, bars show the median and dotted bars the quartiles (F--H). Data are representative of two independent experiments with at least 50 cells analyzed per condition. ^∗^p \< 0.05 by Student's t test. n.s., not significant. Scale bars, 1 μm and 5 μm.

Previous reports have linked changes in mitochondrial morphology to different metabolic phenotypes ([@bib43]). Analysis of the mitochondrial network by confocal microscopy showed that SFB-elicited Th17 cells displayed an elongated mitochondrial morphology ([Figure 7](#fig7){ref-type="fig"}E). In contrast, in *C.*-*rodentium*-elicited Th17 cells, there was a significantly higher fraction of individual (not linked to a network) and shorter mitochondria than in SFB-elicited cells ([Figures 7](#fig7){ref-type="fig"}E--7G). Nonetheless, we did not detect changes in mitochondrial content (evaluated as total mitochondrial area per cell) ([Figure 7](#fig7){ref-type="fig"}H). These results are in line with previous findings associating a tubular and connected mitochondrial network with cells relying mainly in OXPHOS and a more fragmented morphology with cellular populations exhibiting higher glycolytic activity ([@bib4], [@bib37]).

Altogether, these data confirmed that tissue-resident, SFB-elicited Th17 cells, in contrast to *C. rodentium*-induced Th17 cells, showed muted effector functions and a metabolism that supports the attenuated energy requirements of this homeostatic population.

Discussion {#sec3}
==========

Th17 cells are considered important players in the orchestration of inflammatory and autoimmune diseases. Multiple therapeutic approaches targeting Th17 cells or their cytokine IL-17 have shown promising results in ameliorating inflammation ([@bib40], [@bib50]). However, what is rarely taken into consideration is the fact that gut-indigenous Th17 cells are important for barrier protection and might be victims of therapeutic approaches with potential deleterious long-term effects. An example is the unsuccessful targeting of IL-17 in Crohn's patients, which resulted in increased adverse effects ([@bib19]). However, it is clear that Th17 cells are also linked to intestinal inflammatory diseases such as IBD, where they are highly enriched and linked to several genetic risk loci ([@bib22], [@bib25]).

In this study, we have set out to define the differences in intestinal Th17 cells that are either tissue-resident and beneficial for barrier maintenance or induced by infection, effective at dealing with the threat but displaying a highly inflammatory profile.

In mice, Th17 cells in the gut are largely induced by commensal SFB ([@bib20]), which play an important role in gut homeostasis, the development of the mucosal architecture ([@bib52]), as well as induction of immunoglobulin A (IgA) and post-natal maturation of gut immune functions, but are apathogenic ([@bib12], [@bib23], [@bib47], [@bib48]). Thus, the response to SFB that leads to the development of Th17 cells proceeds without epithelial cell damage and inflammatory infiltration of the lamina propria ([@bib5]). Using our IL-17A fate reporter mice ([@bib16]), we noticed that after the extensive re-derivation program of mice prior to the start of the Francis Crick Institute, we had lost SFB and could not detect Th17 cells in the small intestine of our reporter mice. Upon introduction of fecal material from germ-free mice monocolonized with SFB (provided by Cerf-Bensussan), Th17 cells re-colonized the intestine of mice, reaching their maximal induction 2 weeks later. We therefore took advantage of this situation to follow and characterize the development of intestinal Th17 cells induced by SFB. Like SFB, the intestinal pathogen *C. rodentium* tightly adheres to epithelium, but unlike SFB causes epithelial cell death through effectors injected via a type III secretion system ([@bib9]), resulting in the induction of an inflammatory Th17 cells response ([@bib51]). Inflammatory Th17 cells are highly plastic and tend to expand their cytokine repertoire to include IFN-γ, even losing expression of IL-17A as we could determine with our fate reporter system.

Our data show that SFB-induced Th17 cells do not have extensive plasticity and rarely switch on IFN-γ in contrast to Th17 cells that were induced after infection with *C. rodentium*. In fact, a previous study found that resident intestinal Th17 cells transdifferentiate into a regulatory phenotype under inflammatory conditions rather than contribute to inflammation ([@bib13]). Under steady-state conditions, however, we did not observe any acquisition of regulatory T cell markers.

A potential caveat for our studies was the tissue-specific localization of these two bacteria, with SFB resident in the small intestine, whereas *C. rodentium* colonizes the colon. Nevertheless, SFB-elicited Th17 cells are also found in the colon, albeit in smaller numbers than in the small intestine, and Th17 cells induced by *C. rodentium* infection can be found in the small intestine. In our RNA-seq comparison of Th17 cells induced by these different bacteria, we therefore carefully compared both colonic and small intestinal Th17 cells for both conditions. Indeed, SFB-elicited Th17 cells in the colon were very similar to those resident in the small intestine. Th17 cells elicited by *C. rodentium* infection but resident in the small intestine had little in common with the inflammatory Th17 cell population in the colon and rather resembled the muted small intestinal population that arises after SFB colonization, whereas the colonic Th17 population induced after infection was different from all other conditions. Given that we also observed very low mRNA expression of *Il23a* in the small intestine compared with that in the colon, this might explain the reduced cytokine expression of *C.*-*rodentium*-elicited Th17 cells, whose maintenance is dependent on this cytokine.

We therefore focused our analysis on comparing colon-resident Th17 cells either elicited by SFB or by *C. rodentium*.

A series of studies have implicated SFB and the associated Th17 cell response in systemic inflammatory conditions such as EAE or arthritis ([@bib30], [@bib61]). A caveat for these studies is that they used germ-free mice, which are generally deficient in mounting effective immune responses as baseline. Our comparison of mice with diverse microbiota and that contained SFB or no SFB did not indicate any difference in the development of EAE whether or not SFB and intestinal Th17 cells were present. This is in line not only with the specificity of intestinal Th17 cells for SFB ([@bib63]), but also with the fact that induction of EAE is dependent on *de*-*novo*-induced Th17 cells in regional lymph nodes after the immunization protocol. Likewise, our data, using inhibition of egress from draining lymph nodes via administration of FTY720, support the assumption that inflammatory Th17 cells induced by infection with *C. rodentium* arose *de novo* from naive CD4 T cells that then migrated to the colon from local lymph nodes rather than from the expansion of pre-existing resident SFB-elicited Th17 cells.

Although it would be difficult to distinguish resident barrier protective Th17 cells from infection-induced Th17 cells in standard wild-type mice that are bred in SFB-containing conditions, there are distinctions between the two states of Th17 cells that might inform therapeutic targeting of inflammatory Th17 cells. For instance, our group and others reported that intestinal Th17 cells, unlike inflammatory Th17 cells, are not dependent on IL-23 ([@bib10], [@bib17]) so that therapies targeting IL-23 would not endanger indigenous small intestinal Th17 cells. Consistently, mutations in the IL-23 receptor are associated with increased IBD risk and increased protein amounts of IL-23 are observed in subjects with IBD ([@bib21], [@bib25]).

Our RNA-seq analysis highlighted profound differences in metabolic conditions for tissue-resident versus inflammatory Th17 cells, showing that tissue-resident homeostatic Th17 cells mainly use OXPHOS, similarly to quiescent or memory T cells. This metabolic state was also reflected in the morphology of their mitochondria that resembled those previously reported in resting memory T cells. Previous data suggested that Th17 cells, like other T cell effector subsets and unlike regulatory T cells, are highly glycolytic. However, these data were generated exclusively from *in*-*vitro*-differentiated Th17 cells ([@bib36]).

It is likely that, in order to support rapid proliferation and effector functions, infection-induced Th17 cells predominantly use glycolysis, as shown in the RNA-seq and metabolic flux analyses. Therefore, targeting highly glycolytic Th17 cells is likely to spare small intestinal Th17 cells.

A number of studies have focused on defining characteristics of "pathogenic" Th17 cells, which were either derived from *in vitro* differentiation cultures or isolated from the CNS of mice with EAE ([@bib14], [@bib31], [@bib57]). Our analysis of intestinal Th17 cells did not corroborate previously identified markers thought to restrain (CD5L, also known as AIM) or promote (Gpr65, Plzp, and Toso) Th17 cell pathology. This might be due to the fact that *in*-*vitro*-differentiated Th17 cells do not adequately reflect the transcriptomic state of resident intestinal Th17 cells and, on the other hand, that Th17 cells involved in CNS inflammation are dissimilar to Th17 cells induced by an intestinal infection. A comparison of our dataset with previously published gene expression data ([@bib15]) indicated minor overlap, but suggested that a small number of differentially expressed genes reported in non-pathogenic Th17 cells generated *in vitro* were found in those of tissue-resident Th17 cells, whilst some genes expressed in pathogenic Th17 cells were similarly expressed in infection-induced Th17 cells in our dataset.

In conclusion, it appears that resident intestinal Th17 cells, which in mice are almost exclusively induced by recognition of SFB, remain in a non-inflammatory, barrier protective state, display a muted metabolism and do not participate in systemic inflammatory responses.

Even though a small proportion of SFB-specific Th17 cells can be found in peripheral lymphoid organs, they display a resting memory phenotype. Th17 cells induced by a pathogen such as *C. rodentium*, however, generate a vigorous inflammatory response, display substantial plasticity and primarily engage aerobic glycolysis.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**anti-mouse CD16/CD32 purifiedeBiosciencecat\#16-0161-86; RRID: [AB_468900](nif-antibody:AB_468900){#intref0010}APC anti-mouse/human CD11b, clone M1/70Biolegendcat\#101212; RRID: [AB_312795](nif-antibody:AB_312795){#intref0015}APC anti-mouse CD3ε, clone 145-2C11Biolegendcat\#100312; RRID: [AB_312677](nif-antibody:AB_312677){#intref0020}APC anti-mouse Ly-6G/Ly-6C (Gr-1), clone RB6-8C5Biolegendcat\#108412; RRID: [AB_313377](nif-antibody:AB_313377){#intref0025}APC anti-mouse CD19, clone 6D5Biolegendcat\#115512; RRID: [AB_313647](nif-antibody:AB_313647){#intref0030}APC anti-mouse TCR-β chain, clone H57-597Biolegendcat\#109212; RRID: [AB_313435](nif-antibody:AB_313435){#intref0035}APC anti-mouse TCRγδ, clone eBioGL3eBiosciencecat\#17-5711-82; RRID: [AB_842757](nif-antibody:AB_842757){#intref0040}PE-Cy7 anti-mouse CD90.2 (Thy1), clone 53-2.1BD Biosciencecat\#561642; RRID: [AB_10895975](nif-antibody:AB_10895975){#intref0045}Alexa Fluor 700 anti-Mouse CD45, clone 30-F11BD Biosciencecat\#560510; RRID: [AB_1645208](nif-antibody:AB_1645208){#intref0050}BV650 anti-mouse RORγt, clone Q31-378BD Biosciencecat\#564722; RRID: [AB_2738915](nif-antibody:AB_2738915){#intref0055}PE anti-mouse CD4, clone RMA-5Biolegendcat\#100512; RRID: [AB_312715](nif-antibody:AB_312715){#intref0060}PercPcy5.5 anti-mouse TCR-β, clone H57-597Biolegendcat\#109228; RRID: [AB_1575173](nif-antibody:AB_1575173){#intref0065}APC anti-mouse IL-22, clone IL22JOPeBiosciencecat\#17-7222-82; RRID: [AB_10597583](nif-antibody:AB_10597583){#intref0070}Pacific Blue anti-mouse IL-17A, clone TC11-18H10.1Biolegendcat\#506918; RRID: [AB_893544](nif-antibody:AB_893544){#intref0075}PE-Cy7 anti-mouse IFN-γ, clone XMG1.2Biolegendcat\#505826; RRID: [AB_2295770](nif-antibody:AB_2295770){#intref0080}PE anti-mouse CD11c, clone N418Biolegendcat\#117308; RRID: [AB_313777](nif-antibody:AB_313777){#intref0085}APC anti-mouse I-A/I-E (MHC class II), clone M5/114.15.2Biolegendcat\#107614; RRID: [AB_313329](nif-antibody:AB_313329){#intref0090}Pacific blue anti-mouse CD45, clone 30-F11Biolegendcat\#103126; RRID: [AB_493535](nif-antibody:AB_493535){#intref0095}**Bacterial and Virus Strains***C. rodentium* infection strain ICC169Dr.Gad Frankel, Imperial College LondonN/AHis-EspA-expressing *E. coli*Dougan Gordon, Sanger InstituteNA**Chemicals, Peptides, and Recombinant Proteins**DPBS, no calcium, no magnesiumThermoFishercat\#14190250Iscove's Modified Dulbecco's MediumSigma-Aldrichcat\#I3390Fetal Bovine SerumSigma-Aldrichcat\#F7524UltraPure 0.5M EDTAThermoFishercat\#15575020HEPES solutionSigma-Aldrichcat\#H0887penicillin/streptomycinSigma-Aldrichcat\#P7539L-Glutamine (200 mM)ThermoFishercat\#25030149Dithiothreitol (DTT)ThermoFishercat\#R0862DNase IRochecat\#11284932001Liberase TLSigma-Aldrichcat\#5401020001Collagenase VIIISigma-Aldrichcat\#C2139Collagenase DRochecat\#11088882001PercollGE healthcarecat\#17-0891-01phorbol-12-myristate-13 acetate (PMA)Sigma-Aldrichcat\#P8139ionomycinSigma-Aldrichcat\#I0634Brefeldin ASigma-Aldrichcat\#B7651Formaldehyde solutionSigma-Aldrichcat\#F87751M Tris pH 8.0Ambioncat\#AM98565M NaClAmbioncat\#AM9760G20% Sodium dodecyl sulfate (SDS)Ambioncat\#AM9820phenol:chloroform:isoamyl alcohol (25:24:1)Ambioncat\#AM97303M Sodium acetate pH 5.5ThermoFishercat\#AM9740Bovine serum albumin (BSA)New England BioLabscat\#B90005FTY720Cayman Chemicalcat\#10006292Dimethyl sulfoxide (DMSO)Sigma-Aldrichcat\#D2650Emulsion containing MOG~35--55~ and killed *Mycobacterium tuberculosis*Hooke Laboratoriescat\#EK-0111Pertussis toxin, *Bordetella pertussis*Calbiochemcat\#516560Propidium iodideSigma-Aldrichcat\#P4170SFB peptide (NYU_003340) LVFDVQFSGAVPNKTCrick Peptide ChemistryN/APoly-D-LysineSigma-Aldrichcat\#A-003-EMitoTracker Red CMXRosThermofishercat\#M75124',6-diamidino-2-phenylindole (DAPI)Sigma-Aldrichcat\#D9542Alexa Fluor 488 PhalloidinThermofishercat\#A12379**Critical Commercial Assays**MILLIPLEX MAP mouse Th17 Magnetic Bead Panel kitMerckcat\#MTH17-MAG-47KLIVE/DEAD Fixable Near-IR Dead CellThermofishercat\#L10119Fix/Perm buffereBiosciencecat\#00-5523-00SMART-Seq V4 ultra low input RNA kitTakaracat\#634890miRNeasy Micro kitQiagencat\#217084RiboPure RNA purification kitThermofishercat\#AM1924QIAquick PCR Purification kitQiagencat\#28106QuantiFAST SYBR GreenQiagencat\#204056ThermoScript RT-PCR System kitThermofishercat\#11146024PCR Master MixThermofishercat\#4318157EasySep Mouse CD4^+^ T Cell Isolation kitStemcell technologiescat\#19752Ni-NTA Spin kitQiagencat\#31314Seahorse XFp Cell Mito Stress Test kitAgilentcat\#103010-100**Deposited Data**RNA-seq dataThis paperGEO: [GSE130302](ncbi-geo:GSE130302){#interref150}**Experimental Models: Organisms/Strains***Il17a*^Cre^*R26R*^eYFP^miceJackson LaboratoryStock No. 016879**Oligonucleotides***B2m* (Mm00437762_m1)Applied Biosystemcat\#4331182*Saa1 (*Mm00656927_g1)Applied Biosystemcat\#4331182*Fut2 (*Mm00440152_s1)Applied Biosystemcat\#4331182*Duoxa2 (*Mm00470560_m1)Applied Biosystemcat\#4331182*Il23a (*Mm00518984_m1)Applied Biosystemcat\#4331182*Cxcl1 (*Mm00433859_m1)Applied Biosystemcat\#4331182*Cxcl2 (*Mm00436450_m1)Applied Biosystemcat\#4331182*Il1b (*Mm01336189_m1)Applied Biosystemcat\#4331182UniF340 (5′-ACTCCTACGGGAGGCAGCAGT-3′)ThermofisherN/AUniR514 (5′-ATTACCGCGGCTGCTGGC-3′)ThermofisherN/ASFB736F (5′-GACGCTGAGGCATGAGAGCAT-3′)ThermofisherN/ASFB844R (5′-GACGGCACGGATTGTTATTCA-3′)ThermofisherN/A**Software and Algorithms**GraphPad Prism 7.0cGraphPad Software<https://www.graphpad.com/scientific-software/prism/>FlowJo LLC version 10.4.2Becton Dickinson<https://www.flowjo.com/solutions/flowjo/downloads>Ingenuity Pathway Analysis (IPA)QIAGEN[www.qiagen.com/ingenuity](http://www.qiagen.com/ingenuity){#intref0110}Bowtie2[@bib28]N/ARSEM[@bib32]N/ADESeq2 (version 1.16.1)[@bib33]N/AR (version 3.4.1)[@bib42]N/ALimma package[@bib44]N/ADAVID analysis[@bib18]N/APIANO R package[@bib55]N/AMouse genome-scale metabolic model[@bib35]N/AWAVE (version 2.6)Agilent<https://www.agilent.com/en/products/cell-analysis/cell-analysis-software/data-analysis/wave-desktop-2-6>ImageJ/Fiji[@bib46]<https://fiji.sc/#download>SVI HuygensScientific Volume Imaging (SVI)<https://svi.nl/Huygens-Essential>Mitochondrial Network Analysis (MiNA) macro for ImageJ/Fiji[@bib46], [@bib53]N/A

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact (<brigitta.stockinger@crick.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Mice {#sec4.3.1}

*Il17a*^Cre^*R26R*^eYFP^mice (on a C57BL/6 background) were bred and maintained in individually ventilated cages at the Francis Crick Institute, under specific pathogen-free conditions according to the protocols approved by the UK Home Office and the ethics committee (AWERP) of the Francis Crick Institute. Sex-matched male and female littermates were randomly assigned to experimental groups in an age range of 4--10 weeks unless otherwise specified.

Method Details {#sec4.4}
--------------

### Colonization with Segmented Filamentous Bacteria {#sec4.4.1}

Mice in our colony were maintained SFB^−^ unless mentioned otherwise. To colonize mice with SFB, SFB^−^ mice were orally gavaged at weaning with SFB-containing feces collected from SFB^+^ mice housed in our colony. Littermate controls were gavaged with SFB^−^ feces. SFB colonization status was routinely examined before and after SFB gavage by quantitative PCR.

### Quantitative PCR for Segmented Filamentous Bacteria {#sec4.4.2}

Flash-frozen stools were transferred in a Precellys's soil grinding tube (Stretton Scientific) with 500 μl of Tris-EDTA buffer containing 200 mM Tris (pH 8.0), 20 mM EDTA, 200 mM NaCl; 210 μl of sodium dodecyl sulfate (SDS 20%) and 500 μl of phenol:chloroform:isoamyl alcohol (25:24:1) (all from Ambion, Life technologies). Samples were homogenized with a Precellys 24 homogenizer (Bertin Technologies). The aqueous phase was removed after centrifugation and washed with isopropanol and sodium acetate (pH 5.5) (all from ThermoFisher). Samples were incubated at −20°C for 1 h, washed with 70% ethanol (ThermoFisher), resuspended in TE buffer containing 10 mM Tris (pH 8.0) and 1 mM EDTA and incubated at 50°C for 20 min. DNA was further purified using QIAquick PCR Purification kit (Quiagen), quantified with Nanodrop Lite Spectrophotometer (Thermofisher) and diluted to equal concentrations. Quantitative PCR was performed with a QuantStudio Real-Time PCR (Thermofisher) using QuantiFAST SYBR Green (Quiagen), 1 μg/ul BSA (New England BioLabs) and the following primers for Eubacteria (UniF340 and UniR514) and SFB (SFB736F and SFB844R):UniF340: (5′ACTCCTACGGGAGGCAGCAGT-3′)UniR514: (5′ATTACCGCGGCTGCTGGC-3′)SFB736F: (5′-GACGCTGAGGCATGAGAGCAT-3′)SFB844R: (5′GACGGCACGGATTGTTATTCA-3′)

For Eubacterial primers, initial 95°C for 5 min, followed by 45 cycles of 95°C for 10 seconds and 63°C for 45 seconds. For SFB primers initial 95°C for 5 min, followed by 45 cycles of 95°C for 10 seconds and 58°C for 45 seconds. SFB abundance was calculated by the threshold cycle (ΔCt) method and normalized to Eubacteria.

### Quantitative PCR for intestinal tissue {#sec4.4.3}

RNA was isolated from colon or small intestine using the RiboPure RNA purification kit, according to the manufacturer's instructions. One microgram total RNA was reverse-transcribed using the ThermoScript RT-PCR System kit (Applied biosystem) accordingly to manufacturer's instructions. The cDNA served as a template for the amplification of genes of interest and the housekeeping gene (beta-2-microglobulin, β2m) by real-time quantitative PCR, using TaqMan Gene Expression Assays (Applied Biosystems), universal PCR Master Mix (Applied Biosystems) and the ABI-PRISM 7900 sequence detection system (Applied Biosystems). mRNA expression was determined using the ΔCt method, relatively to *B2m* gene expression.

### Infection with Citrobacter rodentium {#sec4.4.4}

For *C. rodentium* infection, a single colony of strain DBS100 (ATCC 51459; American Type Culture Collection) was transferred to Luria-Bertani (LB) broth and grown to log phase, followed by centrifugation and resuspension in PBS. Mice were orally gavaged with 200 μl of PBS containing 2 × 10^9^ *C. rodentium* CFU. To determine bacterial load, tissue pieces were weighed and homogenized in sterile PBS and serial dilutions were plated onto Brilliance *E. coli*/coliform Selective Agar (Fisher Scientific) or LB agar plates (liver) for measurement of colony-forming units (CFU). For the administration of FTY720, six days prior the infection with *C. rodentium* or PBS gavage, mice were intra-peritoneally injected with 3mg/kg FTY720 (Cayman Chemical) resuspended in PBS + 5% DMSO or control vehicle, every day for six days. After *C. rodentium* infection or PBS gavage, the administration of the drug continued every other day until the end of the experiment.

### Cell isolation {#sec4.4.5}

Colon and small intestine were cut open longitudinally and incubated in wash buffer (IMDM 1%FCS, 5 mM EDTA, 10 mM HEPES, penicillin/streptomycin, and 2 mM DTT) for 20 min at 37°C with 200 r.p.m. shaking. Colon tissue was collected, cut into small pieces and incubated in digestion buffer (IMDM supplemented with 1% FCS, 10 mM HEPES, penicillin/streptomycin, 50 μg/ml DNase I (Roche)) containing 0.4cmg/ml Liberase TL (Roche) for 30 cmin at 37c°C with 200 r.p.m. shaking. Small intestinal tissue was collected, cut into small pieces and incubated in digestion buffer (IMDM supplemented with 1% FCS, 10 mM HEPES, penicillin/streptomycin, 50 μg/ml DNase I (Roche)) containing 1 mg/ml collagenase VIII (Sigma) for 10 min at 37°C with 200 r.p.m. shaking. Single-cell suspensions from colon and small intestine were further subjected to 40% Percoll (Amersham) density gradient centrifugation to remove debris. Spinal cord from mice with a clinical score of 3 after immunization with MOG-CFA was mashed through 70-μm mesh filter and subjected to 40% Percoll density gradient centrifugation. Spleen was mashed through 70-μm mesh filter and red blood cells lysed with ACK lysing buffer, containing 0.15 M NH~4~Cl, 1 mM KHCO~3~ and 0.1 mM Na~2~EDTA with adjusted pH 7.2--7.4.

### Flow cytometry and cell sorting {#sec4.4.6}

Single cell suspensions were prepared as described from the indicated organ and incubated with anti-CD16/32 (eBioscience) and fixable live/dead cell dye (ThermoFisher). Cell suspensions for Th17 staining were incubated with antibodies against CD45 (BD Biosciences), CD4 and TCR-β (Biolegend) whereas cell suspensions for ILC3 staining were incubated with antibodies against CD11b, CD3, TCRγδ, Gr1, CD19, TCR-β (all BioLegend) and Thy1.2, CD45 (all BD Biosciences). For intracellular staining, single-cell suspensions were re-stimulated for 2 h in the presence of 1 ng/ml phorbol-12-myristate-13-acetate (PMA), 1μg/ml ionomycin and 10 μg/ml Brefeldin A (all Sigma), washed and stained for surface markers as described above. Cells were then fixed in eBioscence Fix/Perm buffer or 3.7% formaldehyde (for preservation of eYFP fluorescence) for 30 or 10 min on ice, respectively, followed by permeabilization in eBioscience permeabilization buffer for 30 min in the presence of antibodies against IL-22 (eBioscience), IFN-γ and IL17-A (BioLegend) for Th17 or RORγt (BD Bioscences) for ILC3. Samples were FSC-A/SSC-A gated to exclude debris, SSC-W/SSC-A and FSC-W/FSC-A gated to select single cells and gated to exclude live/dead-dye+ dead cells. Th17 cells were gated as CD45^+^CD4^+^TCR-β^+^eYFP^+^. ILC3 cells were gated as CD45^+^CD11b^−^CD3^−^TCRγδ^−^Gr1^−^CD19^−^TCR-β^−^Thy1.2^+^RORγt^+^. Samples were run on a BD Fortessa X20 and analysis was performed with FlowJo v10 (Tree Star) software. For Th17 cell sorting, single-cell suspensions from the spleen were enriched for CD4 T cells with EasySep Mouse CD4^+^ T Cell Isolation kit according to manufacturer's instructions, whereas suspensions from the intestine were FACS-sorted without any prior enrichment. Cell suspensions were stained with propidium iodide (Sigma) to exclude dead cells and with antibodies against CD45, CD4, and TCR-β (all from Biolegend) and Th17 cells sorted as live CD45^+^CD4^+^TCR-β^+^eYFP^+^ cells. For dendritic cell sorting, spleens from RAG-1^−/−^ mice were incubated in digestion buffer (IMDM supplemented with 1% FCS, 10 mM HEPES, penicillin/streptomycin) containing 1 mg/mL Collagenase D and 20 μg/mL DNase I (all from Roche) for 1 h at 37°C. Cell suspensions were then mashed through 70-μm mesh filter, lysed for red blood cells and stained with propidium iodide and antibodies against CD45, CD11c, and MHC-class II (all from Biolegend). Dendritic cells were sorted as live CD45^+^CD11c^+^MHC-class II^high^ cells. Cell sorting were performed using a MoFlo XDP (Beckman Coulter).

### Th17 cell culture {#sec4.4.7}

Th17 cells were sorted as described and plated at 10^4^ cells per well. At 24 h cytokines were measured in the supernatant by MILLIPLEX^®^ MAP mouse Th17 Magnetic Bead Panel kit (Merck). For co-culture experiments Th17 cells were plated at 10^4^ cells per well with dendritic cells at 3:1 ratio, together with 2.5 μM SFB peptide or 1 μg/mL EspA.

### Recombinant proteins {#sec4.4.8}

SFB peptide derived from SFBNYU_003340 (LVFDVQFSGAVPNKT) ([@bib63]) was generated by the Crick Peptide Chemistry platform. EspA was purified from His-EspA-expressing *E. coli* ([@bib26]), kindly provided by Dougan Gordon (Sanger Institute), using Ni-NTA Spin kit (Qiagen) according to manufacturer's instructions.

### EAE induction {#sec4.4.9}

Mice were injected subcutaneously at two sites with 100μl of an emulsion containing 250 μg MOG peptide (amino acids 35--55) and 250 μg killed *Mycobacterium tuberculosis* (strain H37Ra) from Hooke Labs (Hooke Laboratories). Mice received 200 ng *Bordetella pertussis* (Calbiochem) intraperitoneally on the day of immunization and 2 d later. Clinical assessment of EAE was done daily and clinical scores were assigned according to the following criteria: 0, unaffected; 1, flaccid tail; 2, impaired righting reflex and/or gait; 3, partial hindlimb paralysis; 4, total hind limb paralysis. All mice with a clinical score of 4 were killed.

### Colon explant cultures {#sec4.4.10}

Intestinal tissue pieces (0.5--1 cm length) were cultured for 24ch in complete IMDM medium. Cytokines were measured in the supernatant by MILLIPLEX^®^ MAP mouse Th17 Magnetic Bead Panel kit (Merck) and concentrations were normalized to the weight of the explants.

### RNA-sequencing {#sec4.4.11}

Single cell suspensions from small intestine and colon were generated, stained and sorted as described above to purify Th17 cells. Each replicate was pooled from three to six mice and three biological replicates were collected for each group, with the exception of *C. rodentium*-induced colonic Th17 cells, with five biological replicates. RNA was isolated with miRNeasy Micro kit (Quiagen) according to the manufacturer's protocol. Amplified cDNA was prepared using the SMART-Seq V4 ultra low input RNA kit (Takara), according to the manufacturer's instructions. Sequencing libraries were generated using the Ovation Ultralow V2 kit (NuGEN) according to manufacturer's instruction. Libraries were assessed using the TapeStation 2200 (Agilent Technologies) and sequenced by paired-end 100 base pair reads using the Illumina HiSeq platform. Reads were aligned to the GRCm38 Ensembl Release 86 mouse genome using Bowtie2 ([@bib28]) and quantified using RSEM ([@bib32]). Differential genes were found using DESeq2 ([@bib33]) (version 1.16.1) in R ([@bib42]) (version 3.4.1), using a two-factor model with interactions to account for difference between tissues, differences between treatments, and tissue-specific treatment effect. We used a false discovery threshold of 0.05 on the resulting Wald statistic. All four experimental conditions were used to estimate per-gene dispersion values. For the heat map of condition similarity ([Figure 5](#fig5){ref-type="fig"}A), each experimental group was summarized as the sum across replicates of the raw counts. The Poisson distance ([@bib60]) between pairs of experimental groups was taken to assess how similar the conditions are using complete hierarchical clustering. For the scatter plot of differentially expressed genes ([Figure 5](#fig5){ref-type="fig"}C), low normalized read count (average across conditions less than 4) were removed to ensure the trend was not driven by noise: omitting this filtering showed no qualitative difference. For the scatter plot in Fig.S5D we compared our differentially expressed gene list generated from colonic SFB- versus *C. rodentium*-elicited Th17 cells to a publicly available expression dataset (GSE23505). Firstly, we identified the list of differentially expressed genes using the Limma package in R and selected genes that were statistically significant (p value \< 0.001) in the published dataset. We then compared the generated gene list to the differentially expressed genes in our dataset (adjusted p value \< 0.05). For canonical pathway analysis ([Fig.5](#fig5){ref-type="fig"}D), differentially expressed genes between SFB- and *C.*-*rodentium*-elicited colonic Th17 cells with adjusted p value \< 0.05 and fold change \> 1.5 were input in Ingenuity Pathway Analysis (IPA, QIAGEN Redwood City, [www.qiagen.com/ingenuity](http://www.qiagen.com/ingenuity){#intref0135}). Enriched KEGG metabolic pathways ([Fig.6](#fig6){ref-type="fig"}A) and reporter metabolites ([Fig.6](#fig6){ref-type="fig"}B) ([@bib41]) were identified from differentially expressed genes in SFB- versus *C. rodentium*-elicited colonic Th17 cells (adjusted p value \< 0.05). Specifically, we used DAVID analysis ([@bib18]) to identify KEGG enriched pathways from up-regulated genes and PIANO R package ([@bib55]) to identify reporter metabolites from differentially expressed genes. Enzymes, metabolites and their topological relations used for the metabolic analysis were obtained from a mouse genome-scale metabolic model ([@bib35]). In KEGG metabolic pathway analysis, we excluded metabolic pathways not originated from the host, such as biosynthesis of antibiotics, drug metabolism by cytochrome P450 and metabolism of xenobiotics by cytochrome P450. Consistently, in the reporter metabolite analysis, we excluded metabolites originating from these pathways, together with artificial reactions inferred on the genome-scale metabolic model and focused on up-regulated metabolites. A selection of reporter metabolites is displayed in [Fig.6](#fig6){ref-type="fig"}B, the complete list of results can be found in [Table S1](#mmc2){ref-type="supplementary-material"}.

### Metabolic assays {#sec4.4.12}

After FACS-sorting, Th17 cells (7 × 10^4^ per well) were seeded onto standard Seahorse 8-well plates coated with Poly-D-Lysine (50 μg/mL, Sigma) and assayed on a Seahorse XFp Analyzer (Agilent Technologies, Santa Clara, USA). The plates were centrifuged at 300g for 5 min and kept at 37°C for 30--60 min. Oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) were measured in XF media with pH adjusted to 7.4. To investigate mitochondrial respiration and energetic phenotypes Seahorse XFp Cell Mito Stress Test kit (Agilent Technologies) was used. The injection strategy was as follow, first: oligomycin (1 μM at final concentration), second: carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) (1 μM at final concentration), and third: rotenone and antimycin A (0.5 μM at final concentration). The WAVE software (version 2.6) was applied for further data analysis.

### Confocal microscopy {#sec4.4.13}

After FACS-sorting, Th17 cells were cultured in μ-Slide 8 well glass bottom slides (ibidi GmbH) and incubated for 30 min at 37°C with MitoTracker™ Red CMXRos (100 nM, ThermoFisher). After two rinses with PBS, cells were fixed with paraformaldehyde 3.7% for 15 min. DAPI (1 μg/mL, Sigma) and Alexa Fluor™ 488 Phalloidin (150 nM, ThermoFisher) were used for nuclear and actin staining, respectively.

Z-stack images were acquired using a Leica TCS SP8 (Leica Microsystems, Germany) confocal microscope and spatial deconvolution and 3D surface-rendered images were carried out with Huygens Software (SVI, The Netherlands). Mitochondrial morphology was analysed using the macro MiNa in Fiji software ([@bib46], [@bib53]).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Details of the statistical tests applied to replicates of datasets shown in Figures can be found in the corresponding Figure legends. All data points and ''n'' values reflect biological replicates (e.g., mice), except in [Figures 2](#fig2){ref-type="fig"}E, [3](#fig3){ref-type="fig"}B, and 3C where they represent technical replicates. Statistical analyses were performed using GraphPad Prism 10 software.

Data and Code Availability {#sec4.6}
--------------------------

The accession number for the mRNA sequencing data reported in this paper is GenBank: [GSE130302](ncbi-geo:GSE130302){#intref0140}.
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